FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

Unichem Laboratories FDA-483

[ Price : $8.95]

FDA releases an FDA-483 issued following an inspection at Indias Unichem Laboratories drug manufacturing firm.

54 Product-Specific Drug Guidances Out

[ Price : $8.95]

FDA releases 54 product-specific drug guidances to promote generic competition.

Attorneys Analyze Medical Device Guidance Flood

[ Price : $8.95]

Two Kleinfeld, Kaplan and Becker attorneys analyze major medical device guidance documents issued in the first eight months of 201...

FDA Proposes Cutting Device Submission Copies

[ Price : $8.95]

FDA proposes to amend its rules to require a single electronic format submission for medical device premarket filings, rather than...

FDA Making FOIA Changes in Info Regs

[ Price : $8.95]

FDA says it wants to change its public information regulations to incorporate Freedom of Information Act changes and make the proc...

Pediatric Medical Device Development Grants

[ Price : $8.95]

FDA awards another round of pediatric device consortia grants to provide expert support to innovators of medical devices specifica...

FDA Issues Sun Pharmaceutical FDA-483

[ Price : $8.95]

FDA releases an FDA-483 with six observations from an inspection at Sun Pharmaceuticals Halol, India, manufacturing facility.

FDA Proposed Rule Nixes Irradiation Regulation

[ Price : $8.95]

Federal Register proposed rule: FDA proposes to repeal a regulation that requires an FDA-approved NDA or ANDA for any drug product...

FDA Panel to Review Celltrion Rituximab Biosimilar

[ Price : $8.95]

Federal Register notice: FDA announces a 10/10 Oncologic Drugs Advisory Committee meeting to review a Celltrion BLA for a proposed...

Workshop on Evidence-based Transplant Treatment Decisions

[ Price : $8.95]

Federal Register notice: FDA announces a public workshop entitled Evidence-Based Treatment Decision in Transplantation: Patient In...